Loading...

Direct inhibitors of InhA active against Mycobacterium tuberculosis

New chemotherapeutic agents are urgently required to combat the global spread of multi-drug resistant tuberculosis (MDR-TB). The mycobacterial enoyl reductase, InhA, is one of the few clinically-validated targets in tuberculosis drug discovery. Here, we report the identification of a new class of di...

Full description

Saved in:
Bibliographic Details
Published in:Sci Transl Med
Main Authors: Manjunatha, Ujjini H., Rao, Srinivasa P. S., Kondreddi, Ravinder Reddy, Noble, Christian G., Camacho, Luis R., Tan, Bee H., Ng, Seow H., Ng, Pearly Shuyi, Ma, N. L., Lakshminarayana, Suresh B., Herve, Maxime, Barnes, S. Whitney, Yu, Weixuan, Kuhen, Kelli, Blasco, Francesca, Beer, David, Walker, John R., Tonge, Peter J., Glynne, Richard, Smith, Paul W., Diagana, Thierry T.
Format: Artigo
Language:Inglês
Published: 2015
Subjects:
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC4383039/
https://ncbi.nlm.nih.gov/pubmed/25568071
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1126/scitranslmed.3010597
Tags: Add Tag
No Tags, Be the first to tag this record!